$392 Million is the total value of Krensavage Asset Management, LLC's 14 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP | $62,461,000 | -15.0% | 552,019 | -15.6% | 15.95% | -10.5% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $60,156,000 | +0.5% | 519,035 | -29.8% | 15.36% | +5.8% |
| AMGN | Sell | AMGEN INC | $45,037,000 | +1.1% | 243,986 | -6.7% | 11.50% | +6.4% |
| MCK | Buy | MCKESSON CORP | $43,254,000 | +5.4% | 324,243 | +11.3% | 11.04% | +10.9% |
| GILD | Buy | GILEAD SCIENCES INC | $37,763,000 | -4.0% | 533,069 | +2.1% | 9.64% | +1.0% |
| MRK | Sell | MERCK & CO. INC. | $31,286,000 | +4.0% | 515,428 | -6.7% | 7.99% | +9.5% |
| SHPG | Buy | SHIRE PLC-ADR | $24,098,000 | +34.4% | 142,758 | +19.0% | 6.15% | +41.5% |
| RTIX | Buy | RTI SURGICAL INC | $20,541,000 | +2.4% | 4,465,496 | +2.4% | 5.24% | +7.7% |
| IVC | Sell | INVACARE CORP | $19,746,000 | +1.8% | 1,061,615 | -4.8% | 5.04% | +7.2% |
| OFIX | Buy | ORTHOFIX INTERNATIONAL NV | $17,049,000 | +8.6% | 300,049 | +12.4% | 4.35% | +14.3% |
| Sell | SIEMENS HEALTHINEERS AG | $16,566,000 | -0.1% | 399,815 | -0.0% | 4.23% | +5.1% | |
| HYH | Sell | HALYARD HEALTH INC | $10,448,000 | -43.5% | 182,502 | -54.5% | 2.67% | -40.5% |
| JNP | Sell | JUNIPER PHARMACEUTICALS INC | $2,684,000 | -20.5% | 308,478 | -7.3% | 0.68% | -16.5% |
| DRAD | Sell | DIGIRAD CORP | $516,000 | -6.5% | 332,866 | -6.6% | 0.13% | -1.5% |
| VXRT | Exit | VAXART INC | $0 | – | -256,973 | -100.0% | -0.33% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -163,924 | -100.0% | -2.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.